ASX News Health Care Clarity jumps as FDA awards fast track status for PET scan imaging agent Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer… Jonathon Davidson24 January 2025 11:47 (AEDT)2 minute read
ASX News Health Care Clarity progresses SECuRE trial with positive safety results Clarity Pharmaceuticals Ltd (ASX:CU6) has reported positive results from a further stage… Caroline Smith12 September 2024 12:13 (AEDT)2 minute read
ASX News Health Care Clarity Pharmaceuticals achieves recruitment target for phase II SAR-Bombesin prostate cancer trial Clinical-stage radiopharma company Clarity Pharmaceuticals (ASX:CU6) has imaged 50 patients with Cu-SAR-Bombesin… Bianca Gimondo07 November 2023 11:35 (AEDT)2 minute read
ASX News Health Care Clarity Pharmaceuticals’ (ASX:CU6) ongoing trials reach highest dose level Clarity Pharmaceuticals (CU6) has treated the first patient at the highest dose… Bianca Gimondo25 August 2023 13:14 (AEDT)2 minute read